Press Releases Investors Investors Overview News & Events Overview Press Releases IR Calendar Email Alerts Company Info Overview Presentations Contacts FAQ Financial Info Overview Financial Results Income Statement Balance Sheet Cash Flow Stock Data Quote Charts Historical Data SEC Filings Overview All SEC Filings Annual Reports Quarterly Reports Section 16 Filings Governance Board Committees Governance Documents News & Events Overview Press Releases IR Calendar Email Alerts Year All Years 2022 2021 2020 2019 2018 2017 2016 2015 2014 Jul 17, 2017 8:00am EDT Medovex Corporation Announces Pricing of $2.69 Million Concurrent Registered Direct Offering and Private Placement Jul 05, 2017 8:00am EDT Medovex Corporation Updates European Union Launch Progress Jun 27, 2017 8:30am EDT Medovex Corporation Schedules First Human Case for DenerveX(TM) System Jun 16, 2017 9:50am EDT Medovex Corporation Receives First Three Commercial Orders for DenerveX(TM) System Jun 12, 2017 8:00am EDT Medovex Corporation Releases Letter to Shareholders Jun 05, 2017 8:15am EDT Medovex Corporation Receives CE Mark Approval for DenerveX(TM) System Jun 01, 2017 11:00am EDT Medovex Corporation Receives ISO 13485 Certification for the DenerveX(TM) System May 08, 2017 8:00am EDT Medovex Corporation to Attend The NSpine Main Conference June 12-15, 2017 Apr 13, 2017 1:00pm EDT Medovex Corporation Retains CG Capital as Investor Relations Counsel Apr 05, 2017 2:30pm EDT Medovex Corporation Partners with Technology Consult Berlin GmbH in Germany Prev 1 2 3 4 5 6 7 8 9 10 ...14 Next
Jul 17, 2017 8:00am EDT Medovex Corporation Announces Pricing of $2.69 Million Concurrent Registered Direct Offering and Private Placement
Jun 16, 2017 9:50am EDT Medovex Corporation Receives First Three Commercial Orders for DenerveX(TM) System
Jun 01, 2017 11:00am EDT Medovex Corporation Receives ISO 13485 Certification for the DenerveX(TM) System
